CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 362

Industry reads hand-picked by our editors

May 06, 2015

Bloomberg
Glaxo abandons HIV spinoff plan
Reuters
EU watchdog pushes back against UniQure gene therapy critics
Reuters
EU drugs agency tightens rules on experts moving to industry jobs

May 05, 2015

Bloomberg
Bloomberg: Could it be time for Glaxo chief Witty to go?
Reuters
China to stop setting most medicine prices from June 1
In-Pharmatechnologist
Pfizer: To save jobs, eliminate the 'fear culture'

May 04, 2015

Reuters
Success of 'Ice Bucket Challenge' leads to end of Jerry Lewis' muscular dystrophy telethon
Bloomberg
The post-Sovaldi era: Drug makers rush to quell payers' cost fears
Reuters
Bayer buys rights to Isis' anti-clotting drug
Reuters
Supreme Court rejects Bristol-Myers' hep B drug patent case

May 01, 2015

HR Dive
J&J to give parental leave a serious boost
Bloomberg
Drop in biotech stocks helps erase April's market gains
Bloomberg
Mylan chair's pay spiked 46% to $22.5M in 2014
FiercePharma
Current Novo COO (and CEO hopeful) Schultz leaves the company

Apr 30, 2015

Bloomberg
Teva CEO urges Mylan to stop 'mudslinging' over takeover bid
Reuters
FDA panel endorses Amgen skin cancer immunotherapy
WSJ
CA drug cost transparency bill stalls again

Apr 29, 2015

Bloomberg
Mylan hikes Perrigo bid again, this time to $32.7B
Reuters
WHO: Most countries woefully unprepared to fight superbugs
Reuters
AZ heart drug Brilinta on the regulatory fast track for wider use

Apr 28, 2015

In-Pharmatechnologist
WHO: Pharma should give cash, not drugs, to aid Nepal earthquake relief
Reuters
Glaxo shingles vax shows cross-age benefit
Bloomberg
Takeda officials agree to pay $2.3B to settle Actos cases
Reuters
Indian generics firm to recall some drugs after FDA concerns

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
The state of drug pricing in 2024 Supported by GoodRx
Trendline
The latest developments in oncology research Supported by EVERSANA
Webinar - on demand
Biomanufacturing: Scale-up vs Scale-out Economics Custom content for Cytiva

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance Webinar - on demand • Provided by Certara
Trends and Innovations in Life Science Qualitative Research Webinar - on demand • Provided by Konovo
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.